[HTML][HTML] HPV vaccines–a review of the first decade

DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males

H Bergman, BS Buckley, G Villanueva… - Cochrane database …, 1996 - cochranelibrary.com
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination

V Roy, W Jung, C Linde, E Coates, J Ledgerwood… - npj Vaccines, 2023 - nature.com
Abstract Gardasil®(Merck) and Cervarix®(GlaxoSmithKline) both provide protection against
infection with Human Papillomavirus 16 (HPV16) and Human Papillomavirus 18 (HPV18) …

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review

PJ Maver, M Poljak - Vaccine, 2018 - Elsevier
Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in
preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate …

[HTML][HTML] Viral protein-based nanoparticles (part 2): Pharmaceutical applications

R Mellid-Carballal, S Gutierrez-Gutierrez… - European Journal of …, 2023 - Elsevier
ABSTRACT Viral protein nanoparticles (ViP NPs) such as virus-like particles and virosomes
are structures halfway between viruses and synthetic nanoparticles. The biological nature of …

[HTML][HTML] Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of …

CH Bedoya-Pilozo, LGM Magües… - Revista Argentina de …, 2018 - Elsevier
The aim of the present study was to gather information regarding the molecular
epidemiology of Human papillomavirus (HPV) and related risk factors in a group of women …

Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection

G Kamuyu, F Coelho da Silva, V Tenet… - Nature …, 2024 - nature.com
Human Papillomavirus (HPV) type variants have been classified into lineages and
sublineages based upon their whole genome sequence. Here we have examined the …

Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general …

H hui Xu, A Lin, Y hong Chen, S shan Dong… - BMJ open, 2017 - bmjopen.bmj.com
Objectives High-risk human papillomaviruses (hrHPVs) are highly prevalent worldwide, and
HPV genotypes differ between geographical regions; however, sexually transmitted HPV …

[HTML][HTML] Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women …

K van Eer, T Dzebisasjvili, RDM Steenbergen, AJ King - Viruses, 2024 - mdpi.com
HPV16 is occasionally detected in vaccinated women who received the bivalent HPV16/18
vaccine, usually at low viral loads. This study explored potential differences in HPV16 …

A mathematical study of a model for HPV with two high-risk strains

A Omame, D Okuonghae, SC Inyama - Mathematical modelling in health …, 2020 - Springer
A new two-sex deterministic model for two strains (HPV type 16/18 and type 31/45) of human
papillomavirus (HPV) infection is designed and rigorously analyzed to gain insights into its …